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Estimating Odds Ratios in Genome Scans:
An Approximate Conditional Likelihood Approach
Arpita Ghosh,1 Fei Zou,1,2,3 and Fred A. Wright1,2,3,*
Inmodern whole-genome scans, the use of stringent thresholds to control the genome-wide testing error distorts the estimation process,
producing estimated effect sizes that may be on average far greater inmagnitude than the true effect sizes.We introduce amethod, based
on the estimate of genetic effect and its standard error as reported by standard statistical software, to correct for this bias in case-control
association studies. Our approach is widely applicable, is far easier to implement than competing approaches, and may often be applied
to published studies without access to the original data. We evaluate the performance of our approach via extensive simulations for
a range of genetic models, minor allele frequencies, and genetic effect sizes. Compared to the naive estimation procedure, our approach
reduces the bias and the mean squared error, especially for modest effect sizes. We also develop a principled method to construct
conﬁdence intervals for the genetic effect that acknowledges the conditioning on statistical signiﬁcance. Our approach is described
in the speciﬁc context of odds ratios and logistic modeling but is more widely applicable. Application to recently published data sets
demonstrates the relevance of our approach to modern genome scans.Introduction
In genetic studies, it is widely recognized that the control
of genome-wide error requires the use of stringent thresh-
olds for signiﬁcance testing. For genome-wide linkage
scans, standard LOD signiﬁcance thresholds in the range
3.0 to 4.0 correspond to point-wise p values in the range
104 to 105, depending on the model and study design.1
For modern genome-wide association scans (GWASs),
100,000 to 1 million SNP markers may be genotyped,
and control of family-wise error or false discovery rates typ-
ically requires point-wise signiﬁcance thresholds in the
range 107 to 108.2–4 The use of such stringent thresholds
is offset somewhat by the belief that GWAS offer greater
power than linkage studies for detecting complex disease
genes.5 Nonetheless, the application of stringent thresh-
olds distorts the inferential process, producing estimates
of disease risk effect sizes that may be, on average, far
greater in magnitude than the true effect.1,2,6–16 This phe-
nomenon has been described as a form of ‘‘winner’s curse’’
by Zo¨llner and Pritchard16 and others, or as a form of re-
gression to the mean,15 and has profound importance for
genome scans. Although the problem has been described
as primarily an issue of bias, we demonstrate below that
the variance of risk estimates can also be greatly inﬂated
by the selection procedure. Moreover, standard conﬁdence
intervals for risk estimates will have very poor coverage
properties, although this issue seems to have received less
attention.
Consider a genome association scan for a complex dis-
ease in which ten genomic regions contain disease genes,
and each region has a 20% chance of meeting genome-
wide signiﬁcance. Assuming independence of regions, the
genome scan has respectable power 1  (1  0.2)10 ¼ 0.891064 The American Journal of Human Genetics 82, 1064–1074, Mayto achieve signiﬁcance in at least one region. However,
a repeated genome scan of equal size will have power of
only 0.2 for any one region and thus probably not result
in ‘‘replication’’ of the ﬁrst study. A follow-up study might
focus on a single signiﬁcant region, with fewermarkers and
paying a lower penalty for multiple comparisons. But if the
results of the initial genome scan are used as a guide, the
follow-up study is likely to be underpowered, by relying
on an inﬂated estimate of locus disease risk.
As a statistical phenomenon, the winner’s curse should
not be confused with additional sources of bias, including
variations due to genotyping technologies, or heterogene-
ity of patient populations from which samples are
drawn.12,17,18 The winner’s curse is investigated in detailed
simulations elsewhere,8,9,13–16 including a recent paper by
Garner,8 who clariﬁed that the bias can be understood
predominantly through the behavior of Wald statistics
for log-odds ratios.
Although the bias is simple to understand and to docu-
ment, reducing or eliminating it may be nontrivial. Zo¨llner
and Pritchard16 have described a likelihood approach that
requires maximization over numerous parameters, includ-
ing genotype frequencies and penetrance parameters,
along with conditioning on declared statistical signiﬁ-
cance. Their procedure reduces the bias in risk estimation
but cannot be performed with standard statistical software.
Yu et al.15 have recently applied bootstrapping to correct
for signiﬁcance bias. Both of these bias correction ap-
proaches are technically feasible for genome scans, but
they would be highly computationally intensive in that
setting.
We describe our alternative approach for estimating ge-
netic effects in terms of odds ratios, which have numerous
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case-control designs.19 A crucial advantage for case-control
studies is that the odds ratio (OR) may be estimated consis-
tently, whether the study design is prospective or retro-
spective,20 and the OR has an interpretation distinct
from nuisance parameters such as genotype frequencies.
Moreover, in logistic models, the OR retains interpretabil-
ity in the presence of covariates, and such a retention is
increasingly important for complex disease investigations.
In this paper, we introduce a method to correct for sig-
niﬁcance bias in disease association studies, by using
an approximate conditional likelihood. The approach is
directly based on the log(OR) estimate and its standard
error as reported by standard statistical software and applies
todominant, recessive, or additivegeneticmodels.Nomod-
iﬁcation is necessary when covariates such as population-
stratiﬁcation variables have also been ﬁt in the model. The
approachmay even be applied to published results without
access to theoriginaldata. Inaddition,wedevelopamethod
to construct accurate conﬁdence intervals for the OR.
We illustrate the performance of our approach via exten-
sive simulations of a disease SNP analyzed by logistic re-
gression. The simulations cover a range of models, disease
allele frequencies, and OR values. Compared to naive OR
estimation, our approach provides greatly reduced bias
and mean squared error, particularly for the modest effect
sizes likely to be encountered in complex diseases. In addi-
tion, our conﬁdence-interval procedure provides coverage
that is accurate or slightly conservative. Performing simu-
lations for OR values near the null presents a challenge
because signiﬁcant results are very rare when applying
genome-wide thresholds. We thus employ a screening
approach in which a deterministic trend statistic is used
to identify data sets potentially signiﬁcant in logistic
regression.
Material and Methods
We assume a genetic model with one parameter for the effect of
disease genotype, which includes recessive, dominant, and addi-
tive models. We use b ¼ logðORÞ to denote the true loge odds ratio
for disease risk conferred by a referent genotype, or for the contri-
bution of each allele in an additive model. A single locus test
statistic for disease association can be expressed as an estimate
for b divided by an estimate for its standard error,
Z ¼ b^
SE^

b^
, (1)
which is compared to the asymptotic null distribution N(0,1). We
will refer to b^ and SE^ðb^Þ as naive estimators because they are ob-
tained from standard statistical procedures without acknowledg-
ing selection based on signiﬁcance. For our problem, we wish to
estimate b only when the SNP is signiﬁcant in two-sided testing,
i.e., jzj > c for a value c corresponding to genome-wide signiﬁ-
cance. By explicitly considering this selection, below we obtain
three new estimators and a conﬁdence interval procedure. Our
approach offers marked improvements over b^ and standard conﬁ-
dence intervals. Our exposition includes mathematical and moti-The Amvational details that we believe will considerably demystify the
problem, which has until now appeared more obscure and
complex than necessary. The performance of our new estimators
is described in subsection Simulations.
Signiﬁcance Bias
When logistic regression is used to test for genetic association, the
Wald statistic for genetic effect assumes the speciﬁc form of (1),
with numerator and denominator obtained frommaximum likeli-
hood and the information matrix.20–22 However, the essence of
our approach applies to a wide variety of testing procedures, for
which the key requirements typically hold: (1) asymptotically nor-
mality of b^ and (2) consistency of the standard error estimate, so
that SE^ðb^Þ=SEðb^Þ/1. Expressing the test statistic in the form of
Equation (1) provides a straightforward illustration of signiﬁcance
bias and points the way toward corrected estimation procedures.
Related test statistics that are based on maximum likelihood ratios
or efﬁcient scores, or that are directly based on contingency tables,
are all asymptotically equivalent to (1) for local departures from
the null hypothesisH0 : b ¼ 0,23 although this asymptotic equiva-
lence is not necessary to apply our approach. The remainder of this
subsection is similar to Garner,8 but our explicit and expanded
treatment provides the grounds for later development.
For large samples, SE^ðb^Þ does not vary markedly in repeated data
realizations. Thus, the estimate b^ and its statistical signiﬁcance are
highly correlated,8 and the problem can be restated as single-
parameter estimation for a truncated normal distribution. To see
this, we deﬁne m ¼ b=SE^ðb^Þ, with Z _ Nðm,1Þ. Our use of this ap-
proximation follows from the standard result Z  m ¼ ðb^ bÞ=
SE^ðb^Þ/
D
Nð0,1Þ for increasing sample size.24 The statistical proce-
dures to follow are developed entirely within this ‘‘m version’’ of
the problem, which has been greatly simpliﬁed by the variance
standardization.
Our naive estimate of m is m^ ¼ z, and the expectation can be
shown analytically to be
EmðZj jZ j > cÞ ¼ mþ fðc  mÞ  fðc þ mÞ
Fðc þ mÞ þFðc  mÞ, (2)
where f and F are the density and cumulative distribution func-
tion of a standard normal, respectively (see Appendix A). This is
the two-sided rejection version of a result given by Garner.8 As
we detail in the Results, the bias can be substantial in realistic set-
tings. In the special case of thenull hypothesism ¼ 0, it is clear from
Equation (2) that the naive estimate z is unbiased because the two-
sided testing procedure is equally likely to falsely declare positive or
negative risk (i.e., a protective effect of the referent genotype). It is
not clear that the lackof bias fornaive estimationunder thenullhas
been fully appreciated (e.g., Figure 2 in Zo¨llner andPritchard16 does
not display the exact null value). However, this lack of bias requires
averaging over rejections for both positive and negative z. In any
signiﬁcant data set, m^ must be less than c or greater than c and
so will be far from the truth under the null. In other words, the
lack of bias under the null is offset by very large variance.
An Approximate Conditional Likelihood
The approximating distribution of Z suggests a correspondingly
approximate likelihood for m,
LðmÞ ¼ pmðzÞ ¼ fðz mÞ: (3)
The likelihood applies generally to a wide variety of testing pro-
cedures, eliminating any nuisance parameters that have beenerican Journal of Human Genetics 82, 1064–1074, May 2008 1065
included in the modeling, including stratiﬁcation variables, clini-
cal covariates, or the effects of other SNP genotypes. It is easy to
show that the maximum-likelihood estimate (MLE) is m^ ¼ z. A
standard approach to likelihood testing for H0 : m ¼ 0 (Ref. 24)
involves comparing the maximum log-likelihood ratio LLR ¼
2 logðLðm^Þ=Lð0ÞÞ to a c21 density. It is also simple to show that
here LLR ¼ z2, so in terms of both estimation and testing, the like-
lihood simply recapitulates the initial Equation (1). The advantage
to Equation (3), however, is that it provides a simple and transpar-
ent approach to handle the conditioning. Acknowledging the
event that the SNP is declared statistically signiﬁcant, we have
the conditional likelihood
LcðmÞ ¼ pmðzj jZ j > cÞ ¼ pmðzÞ
PmðjZ j > cÞ ¼
fðz mÞ
Fðc þ mÞ þ Fðc  mÞ:
(4)
Under Equation (4), the relationship between numerator and de-
nominator is such that, for a given z, it is quite possible that the
most likely value for m is in the interval [c, c], even though z itself
is conditioned to be outside that range.
By using this conditional approximate likelihood, we now
derive improved estimators of m. For any proposed value of m,
we can convert back to the desired log-odds ratio by using
b ¼ m SE^ðb^Þ, where SE^ðb^Þ is obtained from standard approaches
(i.e., does not consider the signiﬁcance selection). One remarkable
feature of our approach is that we can apply it to published sum-
mary results. To do so, we require only the signiﬁcance threshold
c, b^, and SE^ðb^Þ. The standard error, if not provided directly, can be
inferred from c, b^, and any one of the following: z, the p value, or
an unconditional OR conﬁdence interval.
The Conditional MLE
With the conditional likelihood, the maximum likelihood princi-
ple suggests the MLE estimator,
~m1 ¼ arg max
m
LcðmÞ,
which can be obtained with numerical maximization for any z
and c (hereafter ‘‘~’’ will signify estimates based on the conditional
likelihood). Note that in this setting, the conditional maximum-
likelihood estimate provides no guarantee of unbiasedness or efﬁ-
ciency, a fact that does not appear to have been considered by
other investigators. We have already applied large-sample assump-
tions in constructing the conditional likelihood (4), but as we
show below, other estimators can provide reduced bias or mean-
squared error for certain ranges of m, and therefore b.
Motivated by bias reduction, one might attempt to directly cor-
rect the bias in m^ by solving for m in the equation EmðZj jZj> cÞ ¼ z.
Such an estimator has intuitive appeal, representing the value of
m for which, after conditioning on signiﬁcance, we would have
expected to observe z. Perhaps surprisingly, this ‘‘bias-correction’’
estimator in fact turns out to be ~m1. To see this, we take the deriv-
ative of the conditional likelihood with respect to m, for which the
identity L0cð~m1Þ ¼ 0 implies
z ¼ ~m1 þ fðc  ~m1Þ  fðc þ ~m1Þ
Fðc þ ~m1Þ þ Fðc  ~m1Þ: (5)
Comparing Equation (2) to (5) implies that the bias-correction
estimator and ~m1 are the same. Similar estimators have been exam-
ined in the context of sequential clinical trials, in which effect
parameters are estimated only after a stopping boundary has1066 The American Journal of Human Genetics 82, 1064–1074, Maybeen reached.25 Despite its secondary motivation as a bias-correc-
tion estimator, the conditional MLE ~m1 is not in fact unbiased
because of nonlinearity in the bias of the naive estimator m^.
Moreover, in this setting the conditional MLE has no special
optimality properties, and other estimators may be reasonable.
Nonetheless, we will show that ~m1 is markedly improved over
the naive estimator, both in terms of bias and mean squared error.
The Mean of the Normalized Conditional Likelihood
The motivation to reduce mean squared error (MSE) suggests
another, perhaps less obvious estimator,
~m2 ¼
ðN
N
mLcðmÞdm
ðN
N
LcðmÞdm, (6)
which is easily calculated numerically. ~m2 is the mean of the ran-
dom variable following the distribution LcðmÞ, normalized to be
a proper density. ~m2 has favorable MSE properties when averaged
across a wide range of m. This fact follows from an interpretation
of ~m2 as a posterior mean in a Bayesian treatment of the problem
with a ﬂat prior on m.26 However, ~m2 is considered here as an
entirely frequentist estimate, with bias and error examined at
each value of m and judged accordingly. For jzj near the boundary
c, ~m2 typically represents a less aggressive shrinkage toward 0 com-
pared to ~m1.
A Compromise Estimator
In the treatment below, we will see that the conditional likelihood
is typically skewed, and so ~m1 and ~m2 can differ appreciably for cer-
tain values of z. ~m2 can show greater MSE than ~m1 for m near zero
but is more favorable for m away from zero. Thus, as a practical
compromise, we also examine the estimator
~m3 ¼

~m1 þ ~m2

2,
which balances the strengths of ~m1 versus ~m2.
Illustrations of the Conditional Likelihood
Figure 1 illustrates the conditional and unconditional likelihoods
assuming an illustrative constant threshold c ¼ 5.0. Figures 1A–1C
correspond to z ¼ 5.2, 5.33, and 6.0, respectively. For each panel,
the unconditional likelihood is centered andmaximized at z (indi-
cated by a dot on each plot). For Figure 1A, in which z is only
slightly above the threshold, the conditional likelihood is in con-
trast shifted aggressively toward zero (~m1 ¼ 0:66, ~m2 ¼ 2:53, and
~m3 ¼ 1:60).When z is well above the threshold (z¼ 6.0; Figure 1C),
this shift is much smaller (~m1 ¼ 5:48, ~m2 ¼ 4:94, and ~m3 ¼ 5:21).
For an intermediate z (Figure 1B), the shift is intermediate. Note
that our estimates are obtained here for the m version of the prob-
lem, and the conversion b ¼ m SE^ðb^Þmust be performed before the
results are interpreted on the log-odds scale.
As desired, the conditional likelihood shows a clear shift toward
zero. But why is the shift so extreme, e.g., when z ¼ 5.2? Such a z
value (which is equivalent to m^) has already met genome-wide
multiple-testing correction for statistical signiﬁcance, but a shrink-
age from m^ ¼ 5:2 to ~m1 ¼ 0:66 (for example) will effect a corre-
sponding proportional reduction in the log-odds ratio. Thus, it
seems our proposed estimation procedures can often adjust the
estimated effect size to be practically insigniﬁcant. To see why
the result is reasonable, consider that the conditional likelihood,
as a frequentist construction, makes no judgment about the prior
plausibility of various values of m. When presented with a value z2008
for each m, it considers only the chance that z would have arisen,
given that jzj > c. Figure 1D presents the (truncated normal) con-
ditional densities for z under m ¼ 0.66 and m ¼ 5.2. These m values
were chosen because they represent the conditional and uncondi-
tional MLEs when z ¼ 5.2. Note that these curves are conditional
densities for z, not likelihoods. However, for a ﬁxed value of z, the
relative heights of the two curves reﬂect the conditional likeli-
hoods for the two competing values of m. From the curves, we
can see the value z ¼ 5.2 is 2.773 more likely to arise when m ¼
0.66 than when m ¼ 5.2. Expressed in another way, when m values
are truly of large magnitude, then z tends to overshoot the thresh-
old c by a greater amount than was observed here for z¼ 5.2. Thus,
in this instance, we would conclude that m is not likely to be of
large magnitude.
Our three proposed estimators can be easily computed numeri-
cally, and simple R and Excel programs to do so are available at our
website. By using the threshold c ¼ 5.0 for illustration, we have
calculated the conditional expectations and MSEs for the three es-
timators, shown in Figures 2A and 2B. The three corrected estima-
tors provide dramatically reduced bias compared to the naive esti-
mator for much of the range of m. For m ¼ 0, by symmetry all
estimators are unbiased. For jmj considerably larger than c, all
methods will give estimators near z and will be nearly unbiased.
The corrected estimators tend to undercorrect for small m and over-
correct for large m. The conditional MLE ~m1 can be viewed as a ﬁrst-
order attempt to correct the bias, whereas z occupies the same
range whether m is small or large. In a sense, the corrected estimate
splits the difference between the two extremes, leading to the
observed pattern.
TheMSE for m^ ¼ z is extremely large for m near zero, as predicted.
MSEs for the corrected estimators are considerably smaller in the
range of small to moderate m. As described above, these estimators
Figure 1. Behavior of the Uncondi-
tional and Conditional Likelihoods for m
Unconditional and conditional likelihoods
of m are presented for (A) z ¼ 5.2, (B) z ¼
5.33, and (C) z¼ 6. The location of the ob-
served z is indicated by a black dot on each
plot. The conditional likelihood changes
considerably for small changes in z near c.
For larger z, the conditional likelihood
approaches the unconditional likelihood.
Likelihoods for m < c are negligible and
not shown. (D) shows conditional densities
of z for m ¼ 0.66 and m ¼ 5:2, with the
relative likelihoods highlighted for a fixed
value z ¼ 5.2.
are easily converted to the corresponding
improved log(OR) estimators ~b1, ~b2, and
~b3. Moreover, for large samples, the bias
and MSE properties for m will predomi-
nantly carry over to real data, essentially
with a rescaling of the axes to convert m
to b.
Conditional Conﬁdence Intervals
Proper interpretation of the corrected m es-
timates requires an understanding of esti-
mation error, conditioned on statistical
signiﬁcance. Standard conﬁdence interval (CI) procedures fail in
this setting. For example, after conditioning on signiﬁcance,
a standard 95% CI for m cannot contain 0, for otherwise it would
not have been signiﬁcant. Thus, when m ¼ 0 the standard CI pro-
cedure has zero conditional coverage probability. Zo¨llner and
Pritchard16 addressed this issue by using a standard maximum
likelihood ratio approach applied to the conditional likelihood.
In our setting, a 1 h CI created in this manner would consist
of all m values such that 2logðLcð~m1Þ=LcðmÞÞ% q1h, where q1h is
the 1 h quantile of a c21 density. However, we have shown via
numerical integration that in the m version of the problem, the
true coverage probability of this CI procedure can exhibitmarkedly
conservative or anticonservative departures from 1 h, depending
on the truem. Approaches that use the secondderivative at lnLcð~m1Þ
to estimate the error variance also fail. The difﬁculty arises because
the conditionalMLE is not normally distributed nor is the shape of
LcðmÞ approximately normal for a realized data set.
To create conﬁdence intervals with correct conditional cover-
age, we return to the original Neymanian concept of a conﬁdence
region,23,27 a concept that can always be applied when the dis-
tribution of a test statistic is known for each value of the unknown
parameter. Let Aðm,1 hÞ be an acceptance region depending on m
such that PmðZ˛Aðm,1 hÞjjZj > cÞ ¼ 1 h. Given an observed z,
the conﬁdence region consists of all values m such that
z˛Aðm,1 hÞ. It is straightforward to show that this approach
gives exact coverage probability 1 h for any m. Among possible
acceptance regions, we choose Aðm,1 hÞ as the interval between
the h=2 and 1 h=2 quantiles of the conditional density
pmðzjjZj > cÞ. Note that, although we have presented three com-
peting point estimates for m, our procedure yields only a single
CI. Figure 2C shows the upper and lower conﬁdence limits for
our CI procedure for each z. Note that for jzj near c, the conﬁdenceThe American Journal of Human Genetics 82, 1064–1074, May 2008 1067
interval can contain m ¼ 0. This does not contradict the statistical
signiﬁcance—the intent of the procedure is to obtain correct cov-
erage for any m (including m ¼ 0) after conditioning on signiﬁ-
cance. The conversion of the conﬁdence limits to the b scale is
ðmlowerSE^ðb^Þ,mupperSE^ðb^ÞÞ. Although our procedure is guaranteed
correct conditional coverage in the idealized m setting, our CI for
b relies on large-sample normality assumptions for b^. Thus, we
investigate empirical coverage of our procedure in the Results.
Simulations
To describe our simulations, we begin with basic notation for dis-
ease association studies. We let y denote the disease status (0 ¼
control, 1¼ case) for an individual and x denote the SNP genotype
predictor value. For a biallelic SNP with major allele A and minor
allele a, x is deﬁned as follows for genetic models with respect to a:
recessive additive dominant
x ¼
8<
:
0,AA
0,Aa
1, aa
x ¼
8<
:
0,AA
1,Aa
2, aa
x ¼
8<
:
0,AA
1,Aa
1, aa:
We assume the logisticmodel for a randomly sampled individual
in the population
logðPðY ¼ 1 j xÞ=ð1 PðY ¼ 1 j xÞÞÞ ¼ aþ bx,
for some a, and b is the log-odds ratio for a unit increase in x. Rather
than specify a directly, it is more interpretable to solve for a for
a speciﬁed allele frequency and disease prevalence p. Themarginal
frequency of x is denoted p(x) and is easily calculated from Hardy-
Weinberg assumptions.With ﬁxed disease prevalence, the identity
Figure 2. Estimators and Confidence
Intervals for m with Significance Thresh-
old c ¼ 5
(A) The expectation of naive estimator m^
shows substantial bias and (B) very large
mean squared error for much of the range
of m, whereas the corrected estimators
have lower bias and MSE (C) shows upper
and lower confidence bounds for m as
a function of the observed statistic z.
p ¼Px expðaþ bxÞ
1þ expðaþ bxÞ pðxÞ was used
for calculating a. Finally, solving for the
genotype probabilities conditioned on
case-control status yields
PðX ¼ x jY ¼ 1Þ ¼ pðxÞ
p
expðaþ bxÞ
1þ expðaþ bxÞ,
PðX ¼ x jY ¼ 0Þ ¼ pðxÞ
1 p
1
1þ expðaþ bxÞ:
A standard result is that logistic model-
ing for b applies even when the data are
sampled retrospectively.20
Each data set was simulated and ana-
lyzed in R v.2.5.1. We will denote the
total sample size n ¼ ncases þ ncontrols and
ncases ¼ ncontrols throughout. Most simula-
tions consisted of n ¼ 1000. This sample
size is relatively small for a genome scan
and was intentionally chosen to emphasize any departures from
normality or difﬁculties in estimating SEðb^Þ. We also examined
larger sample sizes for several of the setups to examine the effect of
sample size on bias, MSE, and conﬁdence coverage. We assumed a
disease prevalence of 0.01 throughout—the retrospective sampling
is not very sensitive to this speciﬁcation. We examined b ranging
from 0.7 ðORz0:5Þ to 0.7 ðORz2:0Þ. This range corresponds to
biological plausibility for complex disease11 and ensures that
simulations span the range from low power to high power. For
simplicity, we used c ¼ 5.0, corresponding to a single p value of
5.7 3 107, near the genome-wide threshold considered by
others.2–4
For recessive models, we considered MAF values of 0.25 and
0.5—lower values created small expected cell counts that were
problematic for sample sizes of 500 in each group. For the additive
and dominant models, we considered minor allele frequency
(MAF) values of 0.05, 0.1, 0.25, and 0.5. A single setup consisted
of the genetic model, MAF, and b, and sufﬁcient simulations
were performed for each setup so that 1000 signiﬁcant data sets
were obtained. Setups with b ¼ 0 required on the order of 109 to
1011 simulations for this rariﬁed threshold. We sped up the analy-
sis by ﬁrst applying a chi-square test (Cochran-Armitage trend test
for the additive model) to the data sets, which can be obtained
without iterative maximization. The chi-square statistic was
determined to have a close correspondence to z2 obtained from
the more computationally intensive logistic regression, and a
chi-square statistic R24 was determined to capture essentially all
data sets with z2R c2 ¼ 25. Data sets meeting the chi-square crite-
rion were analyzed via logistic regression in R glm. For data sets
achieving ﬁnal signiﬁcance as determined by logistic regression,1068 The American Journal of Human Genetics 82, 1064–1074, May 2008
Figure 3. Expectations and Mean Squared Errors for the Three Genetic Models under MAF ¼ 0.25
The corrected estimators show greatly improved performance for much of the range of b. The left panels correspond to the recessive
model, the middle panels correspond to the additive model, and the right panels correspond to the dominant model. The top row shows
expected values for the naive and conditional likelihood estimators versus b. The bottom row shows mean squared errors for the estima-
tors. The y axes are rescaled to highlight details—the MSE is considerably larger for the recessive model because of scarcity of the risk
homozygotes.b^ and SE^ðb^Þ were used for obtaining ~b1, ~b2, ~b3, and conditional
conﬁdence intervals.
Results
In all scenarios described here, expectations and mean-
squared errors are calculated conditional on signiﬁcance,
i.e., jzj > c.
Bias
The top row of Figure 3 plots the means for each of the na-
ive and corrected estimators versus b (with corresponding
OR values) for all models, with MAF ¼ 0.25. The naive es-
timator shows very large bias, especially for moderate b. All
of the corrected estimators show dramatically reduced bias
across most of the range examined. For each model, the
corrected estimates tend to undercorrect for small (magni-
tude) b while overcorrecting for large b. All of the methods
become nearly unbiased for large b, as they must, because
the conditional and unconditional likelihoods are nearly
identical when jzj is well beyond c. In terms of bias, ~b1 per-
forms best among the corrected estimates for small b. How-The Amever, the overcorrection of the conditional MLE can be sub-
stantial for moderate to large b, especially for the recessive
model. ~b2 shrinks the estimates toward zero less dramati-
cally, resulting in undercorrection for a larger part of the
range of b. ~b3 strikes a balance between the other two cor-
rected estimates and has much improved bias for moderate
b under the recessive model. All estimators are effectively
unbiased for b ¼ 0. A subtle asymmetry in the plots for pos-
itive and negative logðORÞ, most evident in the recessive
model, occurs because MAF < 0.5 and, for a ﬁxed preva-
lence, the logistic intercept a depends on b.
Mean Squared Error
The corresponding MSE values for the estimators are
shown in the bottom row of Figure 3. The naive estimator
b^ exhibits extremely largeMSE formost b values examined.
For b ¼ 0, this is due to high variance, whereas for moder-
ate b, the naive estimator has low variance but high bias.
The corrected estimators show dramatically improved
MSE for b in the interval [0.3, 0.3] (OR ranging from
0.74 to 1.35) that encompasses the bulk of signiﬁcant asso-
ciations thus far for complex diseases.3,4 The MSEs of ~b1
and ~b2 are predominantly complementary. At b ¼ 0, theerican Journal of Human Genetics 82, 1064–1074, May 2008 1069
Figure 4. Mean Square Errors of the Estimators versus b for MAF Values Ranging from 0.05 to 0.5
The additive model is assumed, with n¼ 1000. The MSEs drop for larger MAF, but the relative performance of the estimators is maintained.MSE ð~b1Þ is fairly low, whereas MSE ð~b2Þ peaks. For larger
magnitude b, the roles reverse. As expected, ~b3 exhibits
a more evenMSE across the range, and represents a reason-
able choice for stable error characteristics. For the additive
and dominant models, b^ exhibits very low MSE for large b.
This phenomenon is not as attractive as it appears, essen-
tially resulting from a boundary effect in which b^ is nearly
constant because z is just barely signiﬁcant. In particular,
for b outside of the plotted range, MSE ðb^Þ rises again to
the varðb^Þ value encountered in the unconditional setting.
The empirical bias and MSE observed in our simulations
essentially follow the results from the m version of the esti-
mation problem, with a rescaling of the axes to convert m
to b. Our empirical results for the remaining MAF values1070 The American Journal of Human Genetics 82, 1064–1074, Mayare plotted in Figure S1 available online and predomi-
nantly follow the results described forMAF¼ 0.25. Figure 4
shows a portion of these results for the additive model, in
which the MSE is shown to drop for all estimators as the
MAF increases. This occurs because for small MAF, the
MSE is largely driven by the heterozygote genotype counts,
which increase with the MAF. The key point of Figure 4 is
that the relative advantages of the corrected estimators are
preserved across a wide range of MAF values.
Conﬁdence Coverage
Figure 5 presents the estimated coverage probabilities of
95% and 90% CIs with MAF ¼ 0.25 for the three models.
The top row shows the results for n ¼ 1000. The coverageFigure 5. Estimates of the CI Coverage Probability Plotted against b for the Three Genetic Models, MAF ¼ 0.25
Black dots correspond to 95% CIs; gray dots correspond to 90% CIs. The dashed curves represent coverage of standard 95% CIs that do not
acknowledge the significance selection. The top row shows n¼ 1000 (500 cases and 500 controls). The bottom row shows n¼ 2000 (1000
cases and 1000 controls). Coverage is close to nominal, except for regions of overcoverage in the recessive model because of small cell
counts (note that the y axis range begins at 0.7). For all models, the coverage will approach the nominal value as the sample size increases
further.2008
is close to the nominal level for almost all the setups, ex-
cept for conservativeness near b ¼ 0 for the recessive
model. The coverage of the naive conﬁdence intervals is
also depicted in the ﬁgure, dropping dramatically out of
the axis range to zero coverage for b of small magnitude.
For n ¼ 2000, the coverage of the proposed procedure
improves further, with a region of modest overcoverage
for recessive models. Results for other MAF values are sim-
ilar, and are presented in Figure S2.
Sample Sizes, Thresholds, and Covariates
Our setup conditions represent a wide range of realistic sce-
narios but cannot represent all situations and complicating
factors. Fortunately, the large-sample behavior of the con-
structed approximate likelihood provides considerable ro-
bustness for our conclusions. Figure S3 shows the results
of increasing sample size for several realistic b values for
the additive model when MAF ¼ 0.25. The bias and MSE
for all theestimators are reducedas the sample size increases.
For each sample size, the corrected estimators show superior
bias and MSE compared to the naive estimator.
In maximum-likelihood settings, the distribution of the
Wald test statistic is predominantly driven by b=SEðb^Þ. This
is also true for our conditional likelihood, because b=SEðb^Þ
determines the noncentrality of the z statistic. For a ﬁxed ra-
tio ncases : ncontrols, the standard error is proportional to 1=
ﬃﬃﬃ
n
p
.
Thus, for the setups in Figure 3 and Figure S1, a doubling of
the sample size ton¼2000 (for example, andassumingcases
and controls remain in the same ratio) would produce qual-
itatively similar results, with perhaps a slight improvement
for the corrected estimates as the normality approximation
improves. Moreover, we canmake the results quantitatively
comparable by appropriate rescaling. For example, for any
value b for n ¼ 1000, the comparable results for n ¼ 2000
should correspond to b0 ¼ b ﬃﬃﬃ2p . Figure S4A demonstrates
an empirical example of this effective rescaling equivalence
for the additive model, MAF ¼ 0.25. Thus, the conclusions
from our simulations extend to larger sample sizes.
Similarly, variations on the threshold c do not have
much impact. A value of c ¼ 5.5 would be considered
quite conservative for genome scans, corresponding
to Bonferroni control of family-wise error at 0.05 for
1.3 million SNPs. Empirical investigation requires many
more simulations to achieve signiﬁcance, but we ﬁnd that
the qualitative behavior of the estimators is unchanged
(Figure S4B).
Finally, we simulated an example in which the additive
model is ﬁt (MAF ¼ 0.25), and the logistic regression in-
cludes an additional continuous covariate [distributed
N(0,1), one ﬁtted regression coefﬁcient] and a discrete cova-
riate [distributed Binomial(2,0.05), two ﬁtted coefﬁcients].
The covariates were independent of case-control status
and the test-locus genotype. The Wald statistic is relatively
insensitive to inclusion of these extra parameters, and the
relative change in degrees of freedom quite minimal.
Accordingly, the results for our corrected estimators are
virtually unchanged compared to the model without cova-The Amriates (Figure S4C—only ~b1 is shown). Covariate consider-
ations are increasingly important in genome scans, for
example to control for confounding population stratiﬁ-
cation.
Analyses of Published Data Sets
Table 1 illustrates our reanalysis of an association study
with a modest number of SNPs, as well as two GWASs, all
of which had been analyzed with additive models. We be-
gin with a brief description of the three studies, followed
by our reanalysis. Yu et al.15 examined the lymphoma re-
sults described inWang et al.,18 with 48 SNPs and a p value
threshold 0.1/48 z 0.002. The standard OR results were
compared to bootstrap bias-corrected15 results, as well as
the results from a larger pooled analysis involving seven
studies.28 The SNPs rs1800629 and rs909253 were found
to be signiﬁcant, with ORs 1.54 and 1.40, respectively.
Todd et al.3 list four signiﬁcant SNPs resulting from two
type 1 diabetes (T1D [MIM 222100]) GWAS studies, high-
lighting for especial consideration those SNPs with p value
less than 5 3 107. In addition, the authors conducted
a larger case-control follow-up study to conﬁrm these re-
sults. Scott et al.4 performed numerous analyses of several
type 2 diabetes (T2D [MIM 125853]) data sets (FUSION,
DGI, and WTCCC/UKT2D). We consider here only the
SNPs reported by the T2D authors using the declared
genome-wide signiﬁcance threshold (p < 5 3 108) for
the combined analysis of all studies.
With only the published odds ratios, p values, and stated
signiﬁcance thresholds, we produced bias-corrected odds
ratios for all of these studies. Our corrected b estimates are
exponentiated so that odds ratios were obtained: For exam-
ple, O~R1 ¼ exp ð~b1Þ. For the two lymphoma SNPs (Table 1,
top section), the p values are slightly above the threshold,
and our bias-corrected estimates shrink the naive OR esti-
mates markedly. Our estimated values match well with
the bootstrap-corrected values obtained by Yu et al.,15 as
well as the pooled analysis results from Rothman et al.28
For the four T1D SNPs (Table 1,middle section), our anal-
ysis results in noticeably less extremeOR estimates (Table 1,
middle section) than those reported by Todd et al.3 The cor-
rected ORs and CIs for the most extreme SNP, rs17696736,
are only slightly changed from the published estimated of
1.37 because the result is so extreme (p ¼ 7.27 3 1014).
However, the follow-up study obtained a considerably
lower value (OR ¼ 1.16), with the 95% CI not overlapping
the earlier estimates, thereby suggesting possible heteroge-
neity in population sampling. For the two least signiﬁcant
T1D SNPs among those considered, the corrected ORs
show a more substantial change. It is worth noting that
the OR estimate corresponding to the SNP rs12708716
was shrunk from 0.77 to ~0.82 by our methods, whereas
the estimated OR from the follow-up study was 0.83. We
also note that for the four signiﬁcant T1D SNPs, as well as
an additional three SNPs approaching signiﬁcance (Table
1 of Todd et al.3), the follow-up study always gave a less ex-
treme OR estimate than the initial studies. This result iserican Journal of Human Genetics 82, 1064–1074, May 2008 1071
Table 1. Original versus Corrected Odds-Ratio Estimates for Three Published Genetic Association Studies
Study SNP
Minor Allele
Frequency p Value
Reported OR,a
(95% CI)
Bootstrapb
Estimates
Bias-Corrected Estimatesc Biasc-
Corrected
(95% CI)
Follow-Upd OR,
(95% CI)O~R1 O~R2 O~R3
Association Study of Lymphoma, Wang et al.18 (318 Cases and 766 Controls)
rs1800629 0.217 5.7 3 104 1.54 1.29 1.08 1.25 1.16 (0.94,1.85) 1.29
rs909253 0.358 7.4 3 104 1.4 1.18 1.06 1.18 1.12 (0.95,1.56) 1.16
GWAS of T1D, Todd et al.3 (2000 Cases and 3000 Controls)
rs17696736 0.423 7.27 3 1014 1.37 (1.27,1.49) - 1.37 1.36 1.37 (1.25,1.49) 1.16 (1.09,1.23)
rs2292239 0.34 1.49 3 109 1.3 (1.20,1.42) - 1.26 1.23 1.25 (1.08,1.42) 1.28 (1.20,1.36)
rs12708716 0.322 1.28 3 108 0.77 (0.70,0.84) - 0.82 0.84 0.83 (0.71,1.00) 0.83 (0.78,0.89)
rs2542151 0.163 8.4 3 108 1.33 (1.20,1.49) - 1.04 1.15 1.09 (0.99,1.44) 1.29 (1.19,1.40)
GWAS of T2D, Scott et al.4 (9521 Cases and 12183 Controls)
rs7903146 0.18 1.0 3 1048 1.37 (1.31,1.43) - 1.37 1.37 1.37 (1.31,1.43)
rs4402960 0.30 8.9 3 1016 1.14 (1.11,1.18) - 1.14 1.14 1.14 (1.10,1.18)
rs10811661 0.85 7.8 3 1015 1.2 (1.14,1.25) - 1.2 1.2 1.2 (1.14,1.26)
rs8050136 0.38 1.3 3 1012 1.17 (1.12,1.22) - 1.17 1.16 1.16 (1.10,1.22)
rs5219 0.46 6.7 3 1011 1.14 (1.10,1.19) - 1.13 1.11 1.12 (1.05,1.19)
rs7754840 0.36 4.1 3 1011 1.12 (1.08,1.16) - 1.11 1.1 1.11 (1.05,1.16)
rs1111875 0.52 5.7 3 1010 1.13 (1.09,1.17) - 1.1 1.09 1.1 (1.00,1.17)
a Standard OR values as reported.
b Bootstrap correction reported in Ref. 15.
c Correction method proposed in this paper.
d Replication or other follow-up result for the SNP.strong empirical evidence for signiﬁcance bias and showed
that corrected OR approaches are needed.
The bottom portion of Table 1 gives the results for the
combined T2D studies. All of the p values are considerably
beyond the signiﬁcance threshold, and so the corrected es-
timates are nearly unchanged from the original estimates.
This phenomenon is hopeful, in the sense that with very
large studies, OR estimates can be attained that will not
be shrunk to irrelevance by corrected OR estimates.
Discussion
We have presented an approach that greatly reduces signif-
icance bias for odds ratios in genome association scans and
that is much simpler than competing approaches. We fa-
vor the use of ~b3 as a general-purpose estimator with fairly
uniform MSE as a function of b. However, all of the three
corrected estimators have greatly superior performance
compared to the naive estimator. Although developed for
case-control applications, our methodology is an effective
blueprint to perform inference whenever aWald-like statis-
tic has been used to declare signiﬁcance. Thus, the general
approach can be used in numerous other settings, includ-
ing regression-based quantitative-trait association analy-
ses. Our results are qualitatively similar to those of other
investigators15,16 (e.g., see bias curves similar to ours in Fig-
ure 2 of Zo¨llner and Pritchard16). Additional comparisons
to these approaches should be performed in future work,
although comparison is complicated by differing genetic
models. To our knowledge, our approach is the only1072 The American Journal of Human Genetics 82, 1064–1074, Maymethod that can perform bias correction based only on
published summary tables.
The widespread application of conditional likelihood es-
timators in genome scans will no doubt be discouraging to
genetic investigators, who may expend considerable time
and expense only to ﬁnd that a signiﬁcant SNP is estimated
to have a very weak effect. Nonetheless, we view this pro-
cess as healthy and necessary for the genetics community,
in particular to tamp down expectations that signiﬁcant
ﬁndings will be easily replicated. The use of our estimators
may also have an additional beneﬁt of discouraging exces-
sive massaging of data and trying various test procedures
to achieve genome-wide signiﬁcance. If a SNP suddenly
becomes signiﬁcant after numerous data manipulation
procedures have been applied, its z statistic is likely to be
only slightly above the threshold c. Thus, as we observed
in the m version of the problem, the conditional-likelihood
estimator will be dramatically shrunk toward the null.
Thus, the estimated SNP effect size will be very modest,
as is appropriate here for a likely spurious ﬁnding.
Our current approach does not explicitly consider multi-
stage or other sequential designs, in which SNPs meeting
a loose standard of signiﬁcance are used for further testing
in a follow-up sample. However, for multistage designs in
which almost all SNPs that will eventually be declared sig-
niﬁcant are carried forward to later stages, the approach
may be used directly. Also, our results technically hold for
a SNP randomly selected from those achieving the signiﬁ-
cance threshold, and thus an additional bias may be antic-
ipated for the most highly signiﬁcant SNPs among a collec-
tion of signiﬁcant SNPs. Although we believe this second2008
source of bias is much less than that produced by signiﬁ-
cance selection, it is the subject of continuing investigation.
Our rejection-sampling scheme was feasible, but it re-
quired a massive number of simulations to provide accu-
rate results. Future work in this area may beneﬁt from
the practical development of importance sampling or
related computational techniques to provide ﬂexible and
accurate simulations conditioned on signiﬁcance.
Appendix A
Derivation of the Conditional Mean for the Naive
Estimator
EðZ jjZ j > cÞ ¼ K1
h Ðc
N zfðz mÞdzþ
ÐN
c
zfðz mÞdz
i
,
where K ¼ Fðc þ mÞ þ Fðc  mÞ
¼ mþ K1
h Ðcm
N xfðxÞdxþ
ÐN
cm xfðxÞdx
i
,
x ¼ z m
¼ mþ K1
h
ð2pÞ12 Ð 12ðcþmÞ2
N
eydy
þð2pÞ12 ÐN1
2ðcmÞ2
eydy
i
, y ¼ 1
2
x2
¼ mþ K1
h
ð2pÞ12e12ðcmÞ2  ð2pÞ12e12ðcþmÞ2
i
¼ mþ fðcmÞfðcþmÞ
K
Supplemental Data
Four ﬁgures are available at http://www.ajhg.org/.
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The URLs for data presented herein are as follows:
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/Omim/
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Note Added in Proof
While this paper was in press, a paper by Zhong, H. and Prentice,
R.L. proposed a similar methodology, with some differences in ap-
proaches to point and interval estimation: Zhong, H. and Prentice,
R.L. (2008). Bias-reduced estimators and conﬁdence intervals
for odds ratios in genome-wide association studies. Biostatistics,
in press.2008
